Shatalov, P.A.; Bukaeva, A.A.; Veselovsky, E.M.; Traspov, A.A.; Bagdasarova, D.V.; Leukhina, I.A.; Shinkarkina, A.P.; Raygorodskaya, M.P.; Murzaeva, A.V.; Mechenici, Y.A.;
et al. Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential. Biomedicines 2025, 13, 2213.
https://doi.org/10.3390/biomedicines13092213
AMA Style
Shatalov PA, Bukaeva AA, Veselovsky EM, Traspov AA, Bagdasarova DV, Leukhina IA, Shinkarkina AP, Raygorodskaya MP, Murzaeva AV, Mechenici YA,
et al. Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential. Biomedicines. 2025; 13(9):2213.
https://doi.org/10.3390/biomedicines13092213
Chicago/Turabian Style
Shatalov, Peter A., Anna A. Bukaeva, Egor M. Veselovsky, Alexey A. Traspov, Daria V. Bagdasarova, Irina A. Leukhina, Anna P. Shinkarkina, Maria P. Raygorodskaya, Alena V. Murzaeva, Yulia A. Mechenici,
and et al. 2025. "Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential" Biomedicines 13, no. 9: 2213.
https://doi.org/10.3390/biomedicines13092213
APA Style
Shatalov, P. A., Bukaeva, A. A., Veselovsky, E. M., Traspov, A. A., Bagdasarova, D. V., Leukhina, I. A., Shinkarkina, A. P., Raygorodskaya, M. P., Murzaeva, A. V., Mechenici, Y. A., Revkova, M. A., Kaprin, A. D., & Shegai, P. V.
(2025). Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential. Biomedicines, 13(9), 2213.
https://doi.org/10.3390/biomedicines13092213
